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QT Monitoring in the ICU: A Benchmark Project 
Executive Summary 
In adult Intensive Care Unit (ICU) patients, does QT/QTc monitoring compared to no 
QT/QTc monitoring affect mortality or ventricular tachyarrhythmia rates during their ICU stay?  
Not monitoring changes in the QT interval can lead to poor outcomes since mortality rates are 
higher in patients with arrhythmias (Uvelin, Pejakovic, & Mijatovic, 2017).  Approximately 
300,000 sudden cardiac deaths occur in the United States each year with an estimated 15,000 
because of a lethal ventricular tachyarrhythmia rhythm called Torsades de Pointes (TdP) that 
occurs when a QT interval is prolonged (Dave, Bessette, & Setnik, 2017).  Some risk factors for 
developing prolonged QT intervals include medication administration, an older age, and 
electrolyte abnormalities. 
This QT/QTc monitoring project entails creation of an electronic health record (EHR) 
flowsheet and Clinical Decision Support System (CDSS), replacing outdated bedside monitors in 
the ICU and Emergency Department (ED), educating all stakeholders, and go-live with the 
project.  Total expected time for this project from approval to go-live is one year.  Major project 
costs during this time will total approximately $200,000.  Return on investment (ROI) would be 
a profit of at least $550,000 if one lawsuit was avoided.  The outbreak of COVID-19 will 
increase ICU censuses and has a treatment regimen that has the possibility of prolonging QT 
intervals.  QT/QTc monitoring has the ability to reduce incidences of unnoticed QT prolongation 
that could lead to ventricular tachyarrhythmias and death, saving many lives. 
Rationale 
Electrical activity of the heart can be recorded using an electrocardiogram (ECG) 
machine.  The QT interval is the portion of the recording that indicates how well the ventricles 
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depolarize and repolarize.  Depolarization causes the muscle to contract while repolarization 
allows the muscle to relax.  A prolonged QT interval would be indicative of a problem with the 
repolarization of the ventricles decreasing how effective the next contraction is.  Since QT 
intervals need to be shorter with a faster heart rate due to the need for the ventricles to repolarize 
faster, a corrected QT (QTc) needs to calculated to ensure a more accurate number (Al-Khatib, 
LaPointe, Kramer, & Califf, 2003).  A QT/QTc prolongation is defined as an interval greater 
than 500 milliseconds (ms) or an increase of greater than 60ms from baseline (Pham et al., 
2016).  Prolongation of the QT/QTc interval has been associated with ventricular arrhythmias 
such as torsades de pointes (TdP) (Hoogstraaten, Rijkenberg, & van der Voort, 2014). 
  Newer bedside ECG monitors can continuously measure, calculate, and detect when the 
QT/QTc is prolonged.  These new monitors can even automatically send these ECG 
measurements and vital signs to EHRs to be validated and charted by the bedside nurse. 
However, not all EHRs are designed with a place to record ECG measurements, much less 
automatically download them from the bedside monitor.   
Approximately 300,000 sudden cardiac deaths occur in the United States each year with 
an estimated 15,000 because of TdP (Dave et al., 2017).  Medication administration is the most 
common cause of prolonged QT/QTc with ICU patients being the most affected (Etchegoyen, 
Keller, Mrad, Cheng, & DiGirolamo, 2017).  Rates of QTc prolongation greater than 500ms are 
found to be from 2.6% to 24% (Sandau et al., 2017).  Developing TdP as a result of these 
prolongations was found to be between 0% (Armahizer et al., 2013) to 3.8% (Hoogstraaten et al., 
2014).  An annual incidence rate of 0.1% was found for TdP or non-sustained ventricular 
tachycardia (nsVT) (Michels, Kochanek, & Pfister, 2016). 
 
QT MONITORING 4 
Literature Synthesis 
Although published guidelines support the need for QT monitoring, many nurses are 
unaware of the need to monitor their high-risk patients for QT prolongation (Barrett, 2015).  The 
American Heart Association (AHA) recommends QTc monitoring on patients with TdP risk 
factors such as “baseline QTc prolongation, who are being started on nonantiarrhythmic drugs 
with known, possible, or conditional risk for TdP” (Sandau et al., 2017).  Other risk factors for 
acquired long QT syndrome (a-LQTS) include, but are not limited to, older age, low body mass 
index (BMI), electrolyte abnormalities, and the use of QTc-prolonging medications 
(Hoogstraaten et al., 2014).  This would mainly apply to all ICU and Emergency Department 
(ED) nurses since they typically take care of critically ill patients on these medications with these 
risk factors. 
It was found that between 35% (George et al., 2015) and 84% (Hoogstraaten et al., 2014) 
of patients were on medications that prolonged the QT interval.  There are a vast number of 
medications that can prolong the QT interval (Farzam & Tivakaran, 2019) and an updated list 
can be found at crediblemeds.org.  It is recommended that patients at risk for developing a-LQTS 
be identified and monitored, especially if they are receiving multiple medications that can 
prolong the QT interval (Beitland, Platou, & Sunde, 2014). 
For these reasons, physicians also need to be aware of the dangers of prolonged QT 
intervals and the drug-to-drug interactions (DDIs) that can lead to a-LQTS.  Being prescribed 
one QT prolonging medication is normally not a problem.  Problems arise when multiple 
medications are prescribed which have drug-to-drug interactions (DDIs).  DDIs are either 
pharmacodynamic (PD-DDI) or pharmacokinetic (PK-DDI) (Armahizer et al., 2013).  PD-DDIs 
happen when two medications that prolong the QT interval are administered together, and PK-
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DDIs occur when a metabolic inhibitor is administered with a QT prolonging medication 
(Fernandes et al., 2019).  A clinical decision support system (CDSS) can effectively reduce the 
odds of QT prolongation occurring in hospitalized patients by reducing the frequency of these 
medications and interactions (Tisdale et al., 2014). 
Classes of medications that can prolong the QT interval include, but are not limited to, 
antiarrhythmics (Uvelin et al., 2017), antibiotics, antimycotics, antidepressives, antipsychotics, 
and sedatives (Beitland et al., 2014).  PD-DDIs involving ondansetron, metoclopramide, and 
amiodarone are of particular concern because they are most likely to prolong the QT interval 
(Fernandes et al., 2019).  Another commonly prescribed medication of concern is diprivan.  
Diprivan has been suggested as the preferred sedative agent in the ICU for patients with a long 
QT interval (Avci et al., 2017).  However, in another study, diprivan administration was found to 
cause a QT prolongation in a little over 4 out of 10 patients with the greatest risk in lower weight 
patients (Scalese, Herring, Rathbun, Skrepnek, & Ripley, 2016).  If the patient’s QT/QTc cannot 
be monitored, these medications should not be prescribed and a different medication used 
(Beitland et al., 2014). 
All ICU-level patients should have a bedside monitor that is able to monitor the QT/QTc 
interval.  This ability would give an audible alarm when the QTc was over 500ms, as this is 
considered “highly abnormal” (Pham, Banks, Narotsky, & Dorman, 2016, p. 439).  The nurse 
could then take immediate action and notify the physician of a change in patient condition.  
Since patients can develop a prolonged QT/QTc anywhere between 15 minutes to 33.8 hours 
after admission (Hoogstraaten et al., 2014),  ICU patients held in the ED should also be 
monitored.  Flowsheets in the EHR also need to be modified so nurses can enter in ECG 
measurements.  Enabling the nurse or physician to trend the QT/QTc measurements would allow 
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them to notice if there has been an increase of greater than 60ms since this is another indicator of 
a-LQTS (Pham et al., 2016). 
Minimum recommendations for QT/QTc monitoring would be an initial 12-lead ECG, 
another after 4 hours, and then daily regardless of continual bedside QT monitoring (Scalese et 
al., 2017).  Further evaluation of these time intervals will need to be reevaluated annually to 
determine the optimal timing.  Amending a current policy on vital signs by adding QT/QTc 
interval documentation every four hours will be suggested with every eight hours as the longest 
time span to go between reassessments (Sandau et al., 2017).  The policy will also need to 
specify which lead to evaluate QTc and frequency of documentation (Sandau et al, 2017).  Lead 
selection should be based on one with the longest T wave without any U waves (Sandau et al., 
2017). 
Stakeholders 
Main stakeholders for implementing QT/QTc monitoring will be bedside nurses, nurse 
managers, nursing clinical coordinators, and physicians.  The BioMedical (BioMed) department, 
Facility Management, and Information Technology (IT) departments will be secondary 
stakeholders.  Nurses, physicians, and IT will need to be brought in early to gain feedback on 
new monitors, EHR build requirements, and EHR alerts.  Doing these things will help manage 
stakeholder expectations and contribute to an environment for success (Alqaisi, 2018).  Biomed 
and Facility Management will need to be brought in later to help install and manage the new 
monitors. 
Planned Evaluation 
Evaluation for this project will be divided into project management success, physician 
and nurse satisfaction, and patient outcome success.  Project management success determination 
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will occur at each meeting and three months after go-live.  All project management goals will be 
given either a “met”, “on-going”, or “not met” determination.  These goals include initial 
approval, inventory of outdated monitors, new monitor selection, capital expense request with 
replacement schedule, replacement of monitors, guideline/policy development, EHR flowsheet 
and BPA development, educational plan, go-live, and continued management and support. 
Physician and nursing success will be determined by satisfaction of the new flowsheet 
and clinical decision support system (CDSS), respectively, and will be measured using the 
System Usability Scale (SUS) (Appendix A).  “The principal value of the SUS is that it provides 
a single reference score for participants’ view of the usability of a product or service” (Martins, 
Rosa, Queirós, Silva, & Rocha, 2015).  It is also a validated tool with consistent reliabilities over 
0.90 (Lewis & Sauro, 2017).  Nursing success will secondarily be measured by flowsheet usage 
as determined by monthly chart audits with a target score of 90%.  This process will be discussed 
in more detail under the “Data Collection Methods” section. 
Patient outcome success will be measured by a reduction in the percentage of in-hospital 
cardiac arrests with an initial rhythm of TdP.  An audit of hospital code blue records for the year 
prior to go-live will be conducted by the project lead.  On-going audits will continue monthly by 
the project lead or a designee.  These numbers will be graphed and trended using Excel and 
distributed to the team and nursing units after each update.  This will give stakeholders feedback 
as to how they are helping to improve patient outcomes and may improve intrinsic motivation 
(Greenhalgh et al., 2017).  
Timetable/Flowchart 
The first step to implement the recommendations would be to propose and get approval 
from the Executive Leadership of the hospital.  Once approved, an inventory of all of the 
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monitors in the ICU and ED will need to be conducted to determine which, if any, patient 
monitors have the needed functionality of assessing the QT/QTc interval.  One week will be 
allocated for the proposal, approval, and inventory process.  Next, three months will be given to 
decide which new monitor will replace the outdated ones since this will involve request for 
proposals and evaluations.  Bedside nurses will be brought in to provide feedback as this will 
improve stakeholder buy-in.  Once this is done, a capital expense request will need to be 
submitted to obtain the needed funds to purchase the new monitors.  A buying schedule to 
replace the monitors that do not have the needed capabilities will need to be developed.  Two 
weeks will be allotted to complete the capital expense request and buying schedule.  
Procurement of the monitors will most likely need to be spread out over a period of time,  
approximately nine months to two years should be sufficient.  This will ensure that all monitors 
are replaced in a timely fashion while meeting budgetary requirements.   
Guidelines/policies will need to be instituted in the critical care departments regarding 
ECG monitoring and patients at high risk for developing a-LQTS.  Policies are important as they 
allow managers and nurses to know what is expected.   They are normally developed to follow 
current evidence-based practice or regulatory standards (Dols et al., 2017).  Since the new 
guidelines/policies will need to be approved by multiple committees, six months will be given to 
accomplish this task. 
A flowsheet and CDSS will need to be developed within the EHR.  Besides initial 
approval, this is the most essential phase of the project.  Seven months will be allocated to 
complete these builds.  Having access to all of this data would be meaningless without being able 
to track the QT/QTc interval trends, therefore the flowsheet will need to have this capability.  
Whether the QT interval is entered manually or is automatically sent from the monitor to the 
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EHR, the QTc interval can be automatically calculated in a preprogrammed data field.  An alert 
will also need to be set up to notify the physician and nurse for any increase of the QTc interval 
over 500ms or greater than 60ms or more over baseline.  Having a graph of the QTc interval will 
provide a quick a visual representation of how this interval has changed over time. 
Informaticists will need to develop the CDSS with physician and pharmacist input.  The 
CDSS will need an alert to notify the physicians and pharmacists whenever a possible 
combination of medications and/or lab results could adversely affect the patient.  Physicians and 
pharmacists will need to determine which medications and medication combinations will need to 
have this notification.  Involving the physicians in this process will help with provider 
acceptance of the notifications as they will be able to review and accept the supporting evidence 
to the recommendations, see they are relevant to their patients, and understand that the patient 
populations are similar (Seneviratne et al., 2019).  These functions will allow modification of the 
treatment regimen to prevent adverse outcomes such as TdP or death. 
An educational plan will also need to be developed and implemented.  Education of the 
bedside nurses is of utmost importance as this will increase organizational competence and 
communication to the stakehholders, which are two main factors in project success (Radujković 
& Sjekavica, 2017; Butt, Naaranoja, & Savolainen, 2016).  An educational power point on the 
importance of QT/QTc interval monitoring is already being developed by the Nursing Education 
and Professional Development (NEPD) department for critical care nurses and telemetry 
technicians due to the annual dysrhythmia exam being revised.  Development began the last 
week of March 2020 and should be deployed in the Learning Management System (LMS) no 
later than the end of May 2020 after approval has been obtained from the LMS Governance 
Committee, of which the NEPD Directors are members.  Appropriate QT/QTc education for 
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physicians and pharmacists will need to be developed by the physician educator and pharmacy 
director, respectively.  Education will also need to be developed for the new guideline/policy and 
will need to be completed before go-live of the new EHR flowsheet.  The NEPD department will 
also need to develop training material, and then find and educate superusers on the new 
flowsheet before go-live.  Finding unit superusers will start once approval is obtained for the 
project and should not be a problem as this activity will help nurses gain points towards their 
Clinical Advancement Program requirements.  Two months should be enough time to train 
superusers to the new flowsheet and is the reason why the education to the new guideline/policy 
needs to be complete before the build is finished.   
The last project management objective is go-live.  Go-live will be scheduled for one year 
after initial approval for the project is granted.  Unit support after go-live will continue for two 
weeks and IT Help Desk will continue indefinitely.  The proposed timeline for this project is 
shown in Appendix B. 
Data Collection Methods 
Data will be collected from stakeholders (i.e. physicians and nurses), the EHR, and 
patient outcomes to determine project success.  Physician and nurse satisfaction data will be 
obtained using the SUS.  Ten physicians and two nurses from each inpatient unit and ED will be 
randomly selected to complete the initial survey with those same people completing all surveys 
afterwards.  Clinical Informaticists will give out and grade the SUSs every three months until an 
average score of 80 is achieved.  This will be indicative of project success and relates to an “A” 
rating (Lewis & Sauro, 2017).  The SUS will also be analyzed using the Mann-Whitney-
Wilcoxon test to determine statistical significance since it will be using ranked ordinal data.  
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Mann-Whitney-Wilcoxon tests have been shown to have sufficient power with low Type 1 errors 
rates with these analyses (Polit & Beck, 2017; de Winter & Dodou, 2010). 
Monthly chart audits done by the Nursing Clinical Coordinators (NCCs) will gather data 
on flowchart usage.  Ten random charts from their unit will be selected and analyzed.  Percent 
usage will be tracked using Excel with the results displayed on each unit to help ensure flowchart 
use.  Target percentage score for each unit will be 90%.  If nurses are not following the new 
guidelines/policies, they will need to be held accountable by their managers. 
Since patient outcome success will be measured by a reduction in the percentage of in-
hospital cardiac arrests with an initial rhythm of polymorphic ventricular tachycardia/TdP, an 
audit of hospital code blue records for the year prior to go-live will be conducted.  On-going 
monthly audits will be done so the numbers can be graphed and trended using Excel.  These 
trends will then be distributed to all nursing units giving all stakeholders feedback. 
Cost/Benefit 
The largest cost for this project will be from the new monitors and employee time.  Based 
on an old quote, replacing the monitors in the ED will cost approximately $80,000.  Biomed will 
take about a month of work time to change out all of the monitors.  With an average salary of 
$25 per hour, this will cost $4,000 (Indeed.com, 2020).  Building the Epic flowsheet and practice 
alert will take two Nursing Informaticists roughly seven months.  Median salary for a Nurse 
Informaticist is $85,000 per year, equating to an approximate cost of $99,000 (Payscale.com, 
2020).  One Nursing Educator will need to devote roughly one month of total work time to this 
project costing about $6,300 (ZipRecruiter.com, 2020).  Giving one hour of total education time 
for each of the roughly 120 critical care nurses will cost around $4,200 (Nursejournal.org, 2020).  
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Adding up all of these main costs puts the total for this project around $200,000 from start to go-
live. 
Non-tangible benefits for this project include the possibility of saving one or more 
person’s life.  As stated previously, there are an estimated 15,000 deaths each year in the United 
States because of TdP (Dave et al., 2017).  Preventing one of those deaths could have tangible 
benefits in saving hundreds of thousands of dollars if it avoids a lawsuit.  Nursing leadership 
needs to listen to staff when they bring up a process or problem that is at high risk for causing 
harm (Cooper, 2016).  Nursing leadership is not immune to legal responsibility because they are 
not actually delivering the care (Cooper, 2016).  In this case, a patient’s family can bring a tort of 
negligence against an employer under the Doctrine of Respondeat Superior for failing to prevent 
a situation that could be reasonably anticipated and prevented since not monitoring the QT/QTc 
could lead to factual causation (Cavico, Mujtaba, Samuel, & Muffler, 2016).  Not including legal 
fees, one lawsuit alone could cost up to the maximum damage cap in Texas of $750,000 (Enjuris 
Editors, 2020). 
Discussion 
 As of this semester, the main aspect of creating a new flowsheet in the EHR has not been 
started.  However, there has been some progress made.  Annual and new hire dysrhythmia testing 
for critical care nurses will now include scenario-based questions on QT prolongation.  These 
nurses will be assigned educational material to help prepare for this test.  Education is the first 
step to changing practice to make care safer for patients as it teaches the “Why” behind the 
importance of this change.  Education is vital in supporting programs that improve patient 
outcomes (Gavine et al., 2016)  because staff need to be able to learn how to use these new tools 
to achieve implementation aims (Rohrer Vitek et al., 2017).  This education will be very timely 
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as treatment for COVID-19 includes using hydroxychloroquine and azithromycin (American 
Heart Association [AHA], 2020).  Guidance from the AHA, the American College of Cardiology 
(ACC), and the Heart Rhythm Society (HRS) regarding the use of this treatment regimen 
includes ECG/QT interval monitoring, correcting electrolyte abnormalities, and avoiding other 
QTc prolonging medications whenever possible (AHA, 2020). 
Recommendations 
Recommendations will be to implement QT/QTc monitoring, create an EHR flowsheet 
and CDSS, and change outdated beside monitors that do not have the capability to monitor QT 
intervals as soon as possible.  Evidence suggests that “modest QTc prolongation in middle-aged 
and older adults may serve as an early marker for serious cardiovascular events and death” and 
that the QTc should be routinely assessed like other vital signs (Giudicessi, Noseworthy, & 
Ackerman, 2019). Therefore, QT/QTc interval monitoring should be added as a routine vital sign 
to be evaluated at the same time as pulse, respirations, etc. for any patient on ECG monitoring, or 
at the least every four hours when assessments are charted.  EHR flowsheet and CDSS creation 
will take time but will allow healthcare workers the ability to track and trend QT/QTc intervals.  
This will help guide treatment to reduce unwanted patient outcomes such as QT prolongation.  
Changing monitors will also take time but will allow nurses to know immediately if the QT 
interval increases to over 500ms and to download directly into the EHR. 
Conclusion 
 QT/QTc monitoring has the ability to reduce incidences of unnoticed QT/QTc 
prolongation that could lead to ventricular tachyarrhythmias and death.  Medication 
administration is the most common cause of QT prolongation which disproportionally affects the 
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more vulnerable ICU patients.  Instituting this one change in practice has the potential to save 
15,000 people, if done nationally, while reducing liability for nurses and hospitals. 
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Appendix A: System Usability Scale 
 
(Lewis & Sauro, 2018) 
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Appendix B: Timeline 
Figure 1: Gantt Chart 
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Figure 2: Gantt Chart (continued) 
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Figure 3: Gantt Chart (continued) 
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Figure 4: Gantt Chart (continued) 
   
